Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02039219Phase 2Terminated
Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
Alcoholic Hepatitis
PrincipalinvestigatorStart date: 2014-11-03
NCT02172898Completed
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium
Alcoholic Hepatitis
PrincipalinvestigatorStart date: 2013-06-01
NCT00650546Phase 2/3Completed
Role of Exenatide in NASH-a Pilot Study
Nonalcoholic Fatty Liver Disease
Principalinvestigator

Research Network

Collaboration Network

21 collaborators·30 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen A. Harrison, MD

Brooke Army Medical Center

Related
16 trials

Shared therapeutic areas:

Nonalcoholic SteatohepatitisNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

Galectin Therapeutics Inc.
Collaborated on 1 trial
Similarity Score24%

Nezam Afdhal, MD

Beth Israel Deaconess Medical Center

Related
5 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score20%

Ming-Shiang Wu, MD, PhD

National Taiwan University Hospital

Related
7 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Similarity Score20%

Yaron Rotman, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
7 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score20%

Michael Roden, Prof., MD

German Diabetes Center

Related
16 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Similarity Score20%

Marc G Ghany, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
14 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score20%

Ram Subramanian, MD

Emory University Hospital (Transplant Center Clinical Research)

Related
1 trials

Shared therapeutic areas:

Nonalcoholic Steatohepatitis

Worked with same sponsors:

Galectin Therapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Mohammad S Siddiqui, MD

Virginia Commonwealth University Medical Center

Related
1 trials

Shared therapeutic areas:

Nonalcoholic Steatohepatitis

Worked with same sponsors:

Galectin Therapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Thomas Schiano, MD

The Mount Sinai Medical Center (Division of Liver Diseases)

Related
1 trials

Shared therapeutic areas:

Nonalcoholic Steatohepatitis

Worked with same sponsors:

Galectin Therapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Brent A Tetri, MD

St. Louis University School of Medicine

Related
1 trials

Shared therapeutic areas:

Nonalcoholic Steatohepatitis

Worked with same sponsors:

Galectin Therapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02039219Phase 2PrincipalInvestigator

Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)

Alcoholic Hepatitis
Terminated
NCT02172898PrincipalInvestigator

Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium

Alcoholic Hepatitis
Completed
NCT00650546Phase 2/3PrincipalInvestigator

Role of Exenatide in NASH-a Pilot Study

Nonalcoholic Fatty Liver Disease
Completed
NCT01899859Phase 1PrincipalInvestigator

Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis

Non-Alcoholic Steatohepatitis (NASH)
Completed

All 4 trials loaded